NPPA rejects Novartis plea to discontinue painkiller Voltaflam Medical Dialogues Team18 Sept 2021 5:04 PM ISTNew Delhi: Rejecting Novartis India Limited's proposal for discontinuation of scheduled formulation viz., Voltafalm 50mg, the National Pharmaceutical...
New brand names authorized for 3 Covid-19 vaccines in Canada, Details Medical Dialogues Team17 Sept 2021 2:18 PM ISTNew Delhi: Three approved Covid-19 vaccines manufacture by Pfizer-BioNTech , Moderna, and AstraZeneca will now be called Comirnaty, SpikeVax, and...
Sanofi plea for Insulin Glargine, Lixisenatide antidiabetic combination rejected by CDSCO panel Medical Dialogues Team16 Sept 2021 4:14 PM ISTNew Delhi: In a major setback to Sanofi India Limited, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
Pfizer gets CDSCO panel marketing authorization for Infliximab Medical Dialogues Team15 Sept 2021 1:52 PM ISTNew Delhi: Granting permission for a local Phase III clinical trial waver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
NPPA authority rejects Cipla's plea to discontinue four HIV drugs including Abamune, Efavir Medical Dialogues Team14 Sept 2021 2:51 PM ISTNew Delhi: Considering the major public interest, the National Pharmaceutical Pricing Authority (NPPA) has rejected Cipla's application to discontinue...
Revise Itolizumab phase 3 study protocol for Covid-19: CDSCO panel tells Biocon Medical Dialogues Team13 Sept 2021 5:26 PM ISTNew Delhi: After reviewing Biocon's Phase III trial protocol for Itolizumab for treating Covid-19 patients, the Subject Expert Committee (SEC)...
Glenmark gets CDSCO panel nod to market Remogliflozin, Vildagliptin, Metformin FDC drug Medical Dialogues Team12 Sept 2021 11:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has given its nod to pharma major Glenmark...
Semaglutide prescription to be restricted to endocrinologists only: CDSCO panel tells Novo Nordisk Medical Dialogues Team11 Sept 2021 4:48 PM ISTNew Delhi: In a major development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has...
37 drug samples including Cipla Acivir-200DT fail to clear CDSCO test, 1 declared misbranded Medical Dialogues Team11 Sept 2021 12:24 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), flagged 37...
No efficacy data of Regdanvimab on COVID variants in India: CDSCO panel rejects Abbott proposal Medical Dialogues Team10 Sept 2021 5:41 PM ISTNew Delhi: In a major setback to Abbott Healthcare, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has...
Zydus Healthcare gets CDSCO panel nod for study of Indacaterol, Budesonide inhaler Medical Dialogues Team10 Sept 2021 2:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has shown a green light to Zydus...
Govt to replace Drugs and Cosmetics Act 1940, forms panel to frame new laws Medical Dialogues Team9 Sept 2021 6:00 PM ISTNew Delhi: The Central government has constituted an eight-member expert committee chaired by the Drugs Controller General of India (DCGI), Dr V.G...
